170476 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving receptors, cell surface antigens or cell surface determinants
PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS
#602Biomarkers associated with schizophrenia
#603NEPHROPATHY BIOMARKER
#604Human biosensors for detecting voltage changes
#605Antibodies against glioma biomarkers
#606Mimetic peptides which modulate L-type calcium channels
#607TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX
#608Methods of identifying insect-TRPA1 modulators
#609Cystic fibrosis transmembrane conductance regulator gene mutations
#610Cold- and menthol-sensitive receptor (CMR1)
#611TRPC6 involved in glomerulonephritis
#612Heat-sensing protein switches and uses thereof
#613HIGH-DENSITY ION TRANSPORT MEASUREMENT BIOCHIP DEVICES AND METHODS
#614TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#615Molecular marker for cancer stem cell
#616Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
#617Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
#618TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY
#619Methods and systems for modulating hormones and related methods, agents and compositions
#620METHODS OF DIAGNOSING AND TREATING ASTHMA
#621Cell surface prostate cancer antigen for diagnosis
#622PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF
#623Peptide mimotopes of claudin 18.2 and uses thereof
#624Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#625Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#626Microvessel endothelial cell surface markers and uses thereof
#627Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#628Anti-Uroplakin II antibodies systems and methods
#629Selection of Agents Modulating Gastrointestinal Pain
#630Conditionally replicating adenovirus
#631Modulators of ATP-binding cassette transporters
#632ARYLQUINOLINE, ARYLQUINOLONE AND ARYLTHIOQUINOLONE DERIVATIVES AND USE THEREOF TO TREAT CANCER
#633CHOLESTEROL EFFLUX CAPACITY ASSESSMENT
#634PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA
#635DIAGNOSTIC BIOMARKERS AND THERAPEUTIC TARGETS FOR PANCREATIC CANCER
#636Detection of oral microbial virulence factors
#637Biomarker and uses thereof
#638Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
#639Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof
#640Prostate specific membrane antigen binding fibronectin type III domains
#641Antibodies that bind OV064 and methods of use therefor
#642MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#643Methods and compositions related to Hsp90 inhibitors and breast cancer
#644Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
#645Methods for the Prognosis of Breast Cancer
#646Methods of identifying modulators of olfactory receptors
#647Methods for discriminating between prostate cancer and a benign prostate-disease
#648Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof
#649B7X and its derivatives for treating and preventing cardiovascular disease
#650ASSAYS FOR IDENTIFYING COMPOUNDS THAT MODULATE BITTER TASTE
#651Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#652Method for isolating apoptotic bodies
#653Cell analysis system, cell analysis program and cell analysis method
#654METHODS FOR IDENTIFYING MODULATORS OF IL-24 MEDIATED APOPTOSIS AND IMMUNOTHERAPY
#655DIAGNOSTIC METHODS FOR NEURAL DISORDERS
#656BIOMARKERS FOR THE DIAGNOSIS OF INTERSTITIAL CYSTITIS
#657DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY
#658Modulators of ATP-binding cassette transporters
#659Corneal endothelial cell marker
#660Method for identifying modulators of notch signaling
#661Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#662MULTIFUNCTIONAL METAL NANOSTRUCTURE AND METHOD FOR PRODUCING SAME
#663Competitive ligand binding assay for detecting neutralizing antibodies
#664Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
#665URINARY NEUROPILIN-1 (NRP-1) AS A PROGNOSTIC MARKER FOR NEPHRITIS AND LUPUS NEPHRITIS
#666Cell analysis using dynamic biophysical methods
#667Human cancer-related gene, its encoded products and applications
#668TSPAN 33 IS A CANDIDATE FOR ANTIBODY TARGETED THERAPY FOR THE TREATMENT OF B CELL HODGKIN LYMPHOMAS
#669Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor
#670Mesothelin domain-specific monoclonal antibodies and use thereof
#671TM4SF1 binding proteins and methods of using same
#672Prevention of tissue ischemia and related methods
#673MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#674PEPTIDOMIMETIC INHIBITORS OF PSMA
#675USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS
#676METHOD TO PREDICT OR DIAGNOSE A COLORECTAL CANCER
#677Human monoclonal antibodies specific for glypican-3 and use thereof
#678Cytotoxic T cell response modifiers
#679LRP-8 binding dual variable domain immunoglobulin proteins
#680Biomarkers for seizures
#681COMPOSITIONS AND METHODS FOR DETECTING, DIAGNOSING, AND TREATING CANCER
#682METHOD OF AGGLUTINATION IMMUNOASSAY
#683Detection and treatment of LRP4-associated neurotransmission disorders
#684Diagnostic markers for multiple sclerosis
#685Feline bitter taste receptors and methods
#686CANCER TREATMENT USING ANTIBODIES THAT BIND CELL SURFACE GRP78
#687In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants
#688Antibodies to MUC16 and methods of use thereof
#689Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof
#690Diagnosis and therapy of cancer involving cancer stem cells
#691F-labelled folates
#692B7-H1 AND SURVIVIN IN CANCER
#693Selection of biological objects
#694Method for detecting low concentrations of specific cell from high concentrations of cell populations, and method for collecting and analyzing detected cell
#695Diagnostic assays and kits for detection of folate receptor 1
#696Method of Diagnosis or Prognosis of a Neoplasm Comprising Determining the Level of Expression of a Protein in Stromal Cells Adjacent to the Neoplasm
#697Antibody drug conjugates
#698Targeting ABCB5 for cancer therapy
#699Microbial glycans as a target of human intelectin
#700Immunity to folate receptors
#701ANTI-ILT7 ANTIBODY
#702MULTICOLOR FLOW CYTOMETRY METHOD FOR IDENTIFYING A POPULATION OF CELLS, IN PARTICULAR MESENCHYMAL STEM CELLS
#703G-protein coupled receptor (GPCR)-based biosensors and uses thereof
#704P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY
#705SLC2A TRANSPORTER INHIBITORS
#706Amplifying rare cell surface markers
#707Hybridoma clones, monoclonal antibodies, and methods of use
#708Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#709Composition for detecting undifferentiated human pluripotent stem cell, monoclonal antibody 6-1 and use thereof
#710PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS
#711Method of isolating circulating tumor cells
#712Caveolin-1 related methods for treating glioblastoma with temozolomide
#713RGMa Fragment Based Diagnostic Assay
#714Detection of specific antigens in a population of antigens
#715Systems, methods, and workflows for optogenetics analysis
#716Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#717INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#718SERCA INHIBITOR AND CALMODULIN ANTAGONIST COMBINATION
#719SCREENING METHOD FOR ION CHANNEL MODULATORS USING MUTATED BKCA CHANNEL
#720COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA
#721METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY
#722Immunogenic antigens from
#723Anti-CDH6 antibody drug conjugates
#724Using phage epitopes to profile the immune response
#725BIOMARKER COMPOSITIONS AND MARKERS
#726Channelrhodopsin variants and uses thereof
#727DIAGNOSIS OF CARCINOMAS
#728THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
#729CANCER TESTIS ANTIGEN SPERM PROTEIN 17 AS A TARGET FOR BREAST CANCER IMMUNOTHERAPY AND DIAGNOSIS
#730Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#731Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases
#732NEW DUAL BIOMARKER OF NEURODEGENERATION AND OF NEUROREGENERATION
#733Recombinant phages and proteins
#734Mucosal membrane receptor and uses thereof
#735Lipopeptides for use in treating liver diseases and cardiovascular diseases
#736Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
#737BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#738METHOD FOR DETECTING PODOCYTES IN URINE
#739Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#740A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA
#741Probiotic Strains for Treating and/or Preventing Diarrhea
#742Methods for identifying arthropod repellents based on modulation of specific ionotropic receptors, and compounds and compositions identified by such methods
#743Methods for Predicting the Survival Time of Patients Suffering from Diffuse Large B-Cell Lymphomas
#744Antibodies specific for CLL-1
#745Real-time analytical methods and systems
#746USING GALECTIN-BINDING CARBOHYDRATES AS PREDICTORS OF MELANOMA PROGRESSION AND METASTASIS
#747High avidity antigen recognizing constructs
#748DETECTION OF MEMBRANE PROTEINS
#749Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#750Positive allosteric modulators and silent allosteric modulators of the Mu opioid receptor
#751Aptamer for periostin and anti-cancer composition including same
#752TEM-1 diagnostic antibodies
#753BIOMARKERS IN CANCER, METHODS, AND SYSTEMS RELATED THERETO
#754METHODS AND MEANS FOR DETECTING CELLS USING SURFACE PLASMON RESONANCE
#755Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#756DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES
#757Diagnostic Biomarkers and Therapeutic Targets for Pancreatic Cancer
#758TREATMENT AND DIAGNOSIS OF CANCER
#759Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
#760MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#761Prion epitopes and methods of use thereof
#762Diagnostic Markers of Indolent Prostate Cancer
#763PODXL PROTEIN IN COLORECTAL CANCER
#764Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor
#765PODXL in bladder cancer
#766ASSAY METHOD
#767MODELS FOR PARKINSON'S DISEASE STUDIES
#768Diagnostic methods for neural disorders
#769Method to determine treatment of acute heart failure
#770Sortilin 1 is a novel inducer of vascular calcification
#771Inhibitors of calcium-activated chloride channels
#772METHODS FOR TREATING, PREVENTING AND PREDICTING RISK OF DEVELOPING BREAST CANCER
#773Method for increasing the sensitivity of immunoassay system through pretreatment of urine with denaturant
#774Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3
#775Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional Activity
#776Method for detecting lung squamous cell carcinoma
#777BIOMARKERS FOR OVARIAN CANCER
#778Methods of evaluating patients using E-cadherin and vimentin
#779Sweet taste receptor chimeric proteins and use thereof
#780Mesothelin antibodies and methods for eliciting potent antitumor activity
#781In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
#782TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
#783LRRC8 proteins and protein complexes and methods for identification of channel modulators
#784Mesothelin domain-specific monoclonal antibodies and use thereof
#785Anti-uroplakin II antibodies systems and methods
#786Diagnostic method for detecting an autoimmune disease
#787LYVE-1 ANTAGONISTS FOR PREVENTING OR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH LYMPHANGIOGENESIS
#788RENAL CELL POPULATIONS AND USES THEREOF
#789IRHOM2 INHIBITION FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#790Methods for Diagnosis, Prognosis and Methods of Treatment
#791METHOD FOR THE SELECTION AND PRODUCTION OF TAILOR-MADE, SELECTIVE AND MULTI-SPECIFIC THERAPEUTIC MOLECULES COMPRISING AT LEAST TWO DIFFERENT TARGETING ENTITIES AND USES THEREOF
#792ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF
#793Methods and kits for measuring von Willebrand factor
#794DETECTING AND SORTING CELLS OR PARTICLES
#795Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#796TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN
#797Method for treating crohn'S disease or ulcerative colitis by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
#798METHOD FOR CATEGORIZING CIRCULATING TUMOR CELLS
#799Methods using Axl as a biomarker of epithelial-to-mesenchymal transition
#800THERAPEUTIC AND DIAGNOSTIC TARGET
#801Histamine 4 receptor partial agonists, inverse agonists or antagonists for use in treating non-autoimmune uveitis
#802Use of anoctamin as a biomarker for radiation biodosimetry
#803Complement split product C4d for the treatment of inflammatory conditions
#804Methods and kits for measuring von Willebrand factor
#805Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology
#806Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#807Aptamer method
#808Anti-CD22 anti-idiotypic antibodies and uses thereof
#809B7 family member zB7H6 and related compositions and methods
#810Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#811Diagnosis and monitoring treatment of prostate cancer
#812Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#813ANTI-PRO87299 ANTIBODIES
#814Modulators of CFTR
#815Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#816MARKERS OF THE MALE UROGENITAL TRACT
#817sAPP-alpha as a Biomarker for Prediction of Inflammatory and Autoimmune-Related Disorders
#818Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#819COMPOSITIONS AND METHODS FOR TREATMENT
#820Cell with surface coated with ANXA1 and use thereof
#821Assay for assessing conformational stability of membrane protein
#822High-affinity monoclonal antibodies to glypican-3 and use thereof
#823COMPOSITIONS AND METHODS FOR TREATMENT
#824COMPOSITIONS AND METHODS FOR TREATMENT
#825COMPOSITIONS AND METHODS FOR TREATMENT
#826COMPOSITIONS AND METHODS FOR TREATMENT
#827Anti-CXADR antibody
#828Anti-CD134 (OX40) antibodies and uses thereof
#829BIOMARKER
#830DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IMMUNE CELL RECEPTORS AND AUTOANTIGENS
#83118F-labelled folate/antifolate analogues
#832Modulators of ATP-Binding Cassette Transporters
#833Method For Detecting And Purifying Pancreatic Beta Cells
#834Quantitative determination of biomarkers in the erythrocyte membrane
#835Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer
#836Composition for diagnosing liver cancer and methods of diagnosing liver cancer and obtaining information for diagnosing liver cancer
#837Composition and method for measuring thallium influx and efflux
#838MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#839Methods and Compositions for Providing a Preeclampsia Assessment
#840PROCESS OF DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC MONITORING OF SOLID TUMORS
#841Cancer treatment and monitoring methods using OX40 agonists
#842Modulators of ATP-Binding Cassette Transporters
#843Prostate Tumor Markers And Methods Of Use Thereof
#844Method for increasing the proportion of animal cells secreting galectin-9
#845DIAGNOSTIC KITS TO DETECT SP22 AND SP22 ANTIBODIES
#846Cancer-related extracellular matrix signatures and related methods and products
#847MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#848Cancer Biomarkers and Methods of Use
#849Modulators of ATP-Binding Cassette Transporters
#850MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#851Anti-mesothelin antibodies and immunoconjugates
#852Retrieval of biological materials from the human uterus, ovary and cervix by suction
#853EXPRESSION CONSTRUCTS ENCODING G PROTEIN COUPLED RECEPTORS AND METHODS OF USE THEREOF
#854COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST
#855Composition and method for diagnosis and immunotherapy of lung cancer
#856GENETICALLY MODIFIED RAT MODELS FOR PAIN
#857BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS
#858Synthesis and application of novel imaging agents conjugated to DPA 713 analogs for imaging inflammation
#859DUAL FUNCTION MARKERS FOR DIAGNOSTICS AND THERAPEUTICS FOR UPPER GASTROINTESTINAL TRACT PRECANCER
#860Identification of olfactory receptors sensitive to different odorants
#861URINARY BIOMARKER FOR URINARY TRACT CANCER AND APPLICATION OF THE SAME
#862Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
#863MAMMALIAN HOMOLOGUES OF FLOWER, THEIR USE IN CANCER DIAGNOSTICS, PREVENTION AND TREATMENT
#864MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#865Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
#866BIOMARKER PANELS, DIAGNOSTIC METHODS AND TEST KITS FOR OVARIAN CANCER
#867ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF AFFECTIVE AND ANXIETY DISORDERS
#868Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#869Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
#870EXTRACELLULAR AND MEMBRANE-ASSOCIATED PROSTATE CANCER MARKERS
#871Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy
#872METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE
#873Methods of screening T1R hetero-oligomeric taste receptors for sweet taste modulators
#874INCREASED AQUAPORIN EXPRESSION ON CELLULAR MEMBRANE TO IMPROVE CRYOPRESERVATION EFFICIENCY
#875Toll-like receptor 2 binding epitope and binding member thereto
#876COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#877Diagnosis and treatment for respiratory tract diseases
#878MSC surface marker
#879DIAGNOSIS AND TREATMENT OF TUMORS
#880Methods of enhancing translocation of charged analytes through transmembrane protein pores
#881Catalyst and process for preparing acrolein and/or acrylic acid by dehydration reaction of glycerin
#882Methods of identifying, isolating and using odorant and aroma receptors
#883INHIBITION OF PATTERN RECOGNITION RECEPTORS IN PANCREATIC CANCER TREATMENT USING TLR INHIBITORS
#884MCT protein inhibitor-related prognostic and therapeutic methods
#885COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#886BIOMARKER FOR MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS, AND METHOD USING SAID BIOMARKER TO DETECT MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS
#887CONGESTIVE HEART FAILURE BIOMARKERS
#888Cell surface display, screening and production of proteins of interest
#889Variant Fc-polypeptides with enhanced binding to the neonatal Fc receptor
#890Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#891Modulators of ATP-binding cassette transporters
#892REAGENT FOR LABELING PRIMARY AMINE GROUPS IN PROTEINS
#893Detection of human somatic cell reprogramming
#894Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#895Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling
#896CTC BIOMARKER ASSAY TO COMBAT BREAST CANCER BRAIN METASTASIS
#897TSPO-targeting compounds and uses thereof
#898Method of reversibly staining a target cell
#899Systems, methods, and workflows for optogenetics analysis
#900Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders